Athens Medical Center S.A.
- Address
- lock Available on a paid plan
Pulmonology and Respiratory Research
At Athens Medical Center S.A., the Pulmonology Department is involved in studies focused on respiratory tract diseases, especially idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. These trials are exploring new ways to improve breathing function and slow disease progression in people with serious lung conditions.
- Idiopathic pulmonary fibrosis
- Progressive pulmonary fibrosis
- Improving lung function and treatment outcomes
The research aims to evaluate potential therapies that may help preserve forced vital capacity and support long-term respiratory health.
Cardiovascular Medicine
This site is also contributing to studies in cardiovascular diseases, with research centered on acute coronary syndrome and heart failure with systemic inflammation. The trials are designed to test new treatment options that could lower the risk of major heart-related events and improve outcomes for patients with complex cardiac disease.
- Acute coronary syndrome
- Heart failure with mildly reduced or preserved ejection fraction
- Reducing cardiovascular risk and disease complications
These investigations focus on whether emerging therapies can better protect patients from cardiovascular death, myocardial infarction, and worsening heart failure.
Metabolic and Weight-Related Disorders
Clinical research at the Athens Medical Center S.A. includes nutritional and metabolic diseases, particularly obesity, overweight, and type 2 diabetes. These studies are examining innovative approaches to support weight loss and improve blood sugar control in adults living with metabolic disease.
- Obesity
- Overweight
- Type 2 diabetes
The goal is to assess whether new therapies can help reduce body weight, improve glycaemic control, and lower long-term health risks linked to metabolic disorders.
Neurology and Immune-Mediated Disease
The site participates in trials within nervous system diseases, including research in multiple sclerosis. These studies are aimed at understanding long-term safety and tolerability of new treatments that may help manage disease activity and support patients with relapsing or progressive forms of the condition.
- Relapsing multiple sclerosis
- Progressive multiple sclerosis
- Evaluating safety and disease control
This area of research reflects a broader effort to improve care for people with chronic neurological disease through better treatment options.
Musculoskeletal and Inflammatory Conditions
Research in musculoskeletal diseases at this hospital includes studies of moderate to severe rotator cuff tendinopathy and active idiopathic inflammatory myopathy. These trials are assessing whether new therapies can ease symptoms, improve physical function, and offer better control of inflammatory disease.
- Moderate to severe rotator cuff tendinopathy
- Active idiopathic inflammatory myopathy
- Relieving pain and improving function
The overall focus is on testing treatments that may enhance mobility and quality of life for patients with both inflammatory and orthopedic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 31 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Athens Medical Center S.A.
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Yet Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 31 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ADMILPARANT | 2 | Unknown | 2024-06-24 | 2024-07-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.